NUS NUS ニュ― スキン エンタ―プライズ

 NUSのチャート


 NUSの企業情報

symbol NUS
会社名 NU Skin Enterprises Inc. (NUS ニュ― スキン エンタ―プライズ)
分野(sector)   
産業(industry)   
業種 トイレタリ―用品   一般消費財(Consumer Products)
概要 事業概要 ニュー・スキン・エンタープライズ(Nu Skin Enterprises Inc.)はパーソナル・ケア製品と栄養補助食品及び他の製品・サービスの開発・販売に従事する直接販売会社である。同社は「Nu Skin」と「Pharmanex」というブランドでアンチエイジング・パーソナル・ケア製品と栄養補助食品を提供する。「Nu Skin」というブランドはageLOC Meカスタマイズ・スキン・ケア・システム、ageLOC Spaシステム、ageLOC Transformationアンチエイジング・スキン・ケア・システム等の製品を提供する。「Pharmanex」製品ラインにはageLOC Youth栄養補助食品、ageLOC TR90体重管理と体型形成システム、LifePak栄養補助食品を含む。同社は中国、北アジア、米州、南アジア・太平洋、ヨーロッパ、中東、アフリカ(EMEA)を含む地域において事業を運営する。同社はageLOC Youth栄養補助食品とageLOC Meパーソナライズド・スキン・ケア・システムの提供に従事する。同社はまた家庭用製品と技術サービスを提供する。  ニュ―スキン・エンタ―プライズは、米国の化粧品・栄養補助食品メ―カ―。日用品、化粧品、栄養補助食品を製造し、消費者へ直接販売する。主にパ―ソナルケア製品を「ニュ―スキン」の商標名で、栄養補助食品を「ファ―マネックス」の商標名で開発、販売。その他の商標名は「トゥル―フェイス」、「エイジロック」、「ガルバニックスパ」など。本社はユタ州。  Founded more than 35 years ago, Nu Skin Enterprises, Inc. empowers innovative companies to change the world with sustainable solutions, opportunities, technologies and life-improving values. The company currently focuses its efforts around innovative consumer products, product manufacturing and controlled environment agriculture technology. The NSE family of companies includes Nu Skin, which develops and distributes a comprehensive line of premium-quality beauty and wellness solutions through a global network of sales leaders in Asia, the Americas, Europe, Africa and the Pacific; and Rhyz, company's strategic investment arm that includes a collection of sustainable manufacturing and technology innovation companies.
本社所在地 801 345-1000
代表者氏名 Steven J. Lund
代表者役職名 Executive Chairman of the Board
電話番号 +1 801-345-1000
設立年月日 1984年
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 4900人
url www.nuskinenterprises.com
nasdaq_url
adr_tso
EBITDA EBITDA(百万ドル) 394.54900
終値(lastsale)
時価総額(marketcap)
時価総額 時価総額(百万ドル) 2649.57700
売上高 売上高(百万ドル) 2679.00800
企業価値(EV) 企業価値(EV)(百万ドル) 2681.78300
当期純利益 当期純利益(百万ドル) 121.88700
決算概要 決算概要 BRIEF: For the fiscal year ended 31 December 2018 Nu Skin Enterprises Inc. revenues increased 18% to $2.68B. Net income before extraordinary items decreased 31% to $121.9M. Revenues reflect Mainland China segment increase of 24% to $886.5M Europe/Other Foriegn segment increase from $6.3M to $94M. Net income was offset by Selling expenses increase of 14% to $1.07B (expense) General and administrative expenses-bal increase of 14% to $612.7M (expense).

 NUSのテクニカル分析


 NUSのニュース

   Nu Skin Enterprises Consensus Indicates Potential 5.7% Upside  2021/06/11 06:24:30 DirectorsTalk
Nu Skin Enterprises with ticker code (NUS) have now 6 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 80 and 60 calculating the mean target price we have 66. Given that the stocks previous close was at 62.44 this would indicate that there is a potential upside of 5.7%. There is a 50 day moving average of 58.01 and the 200 moving average now moves to 54.78. The market cap for the company is $3,046m. Visit the company website at: /> [stock_market_widget type="chart" symbol="NUS" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Nu Skin Enterprises develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products.
   Nu Skin Shines After 3 Quarters Double- And Triple-Digit Profit, Sales Growth  2021/06/09 23:23:00 Investor''s Business Daily
A Relative Strength Rating upgrade for Nu Skin Enterprises Inc shows improving technical performance. Will it continue?
   Facial Cleansing Devices Market Huge Growth Opportunities by 2029 | Industry Analysis, Growth Factor and Segmental Overview | Procter & Gamble, Philips, Panasonic, Nu Skin Enterprises, LOréal (Clarisonic), Conair, MTG  2021/06/09 12:46:58 OpenPR
The Market Abstract of Facial Cleansing Devices Market The Facial Cleansing Devices market report is designed to include both qualitative and quantitative aspects of the business in globally each region and country participating in the study. The report also offers detailed
   Nu Skin Enterprises Stock Gives Every Indication Of Being Fairly Valued  2021/06/05 12:00:11 GuruFocus
Related Stocks: NUS ,
   Nu Skin Enterprises Consensus Indicates Potential 8.5% Upside  2021/06/04 12:24:24 DirectorsTalk
Nu Skin Enterprises found using ticker (NUS) have now 6 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 80 and 60 calculating the average target price we see 66. With the stocks previous close at 60.82 this now indicates there is a potential upside of 8.5%. The 50 day MA is 56.88 while the 200 day moving average is 54.42. The market cap for the company is $3,022m. Find out more information at: /> [stock_market_widget type="chart" symbol="NUS" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Nu Skin Enterprises develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products.
   Nu Skin Enterprises Consensus Indicates Potential 5.7% Upside  2021/06/11 06:24:30 DirectorsTalk
Nu Skin Enterprises with ticker code (NUS) have now 6 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 80 and 60 calculating the mean target price we have 66. Given that the stocks previous close was at 62.44 this would indicate that there is a potential upside of 5.7%. There is a 50 day moving average of 58.01 and the 200 moving average now moves to 54.78. The market cap for the company is $3,046m. Visit the company website at: /> [stock_market_widget type="chart" symbol="NUS" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Nu Skin Enterprises develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products.
   Nu Skin Shines After 3 Quarters Double- And Triple-Digit Profit, Sales Growth  2021/06/09 23:23:00 Investor''s Business Daily
A Relative Strength Rating upgrade for Nu Skin Enterprises Inc shows improving technical performance. Will it continue?
   Facial Cleansing Devices Market Huge Growth Opportunities by 2029 | Industry Analysis, Growth Factor and Segmental Overview | Procter & Gamble, Philips, Panasonic, Nu Skin Enterprises, LOréal (Clarisonic), Conair, MTG  2021/06/09 12:46:58 OpenPR
The Market Abstract of Facial Cleansing Devices Market The Facial Cleansing Devices market report is designed to include both qualitative and quantitative aspects of the business in globally each region and country participating in the study. The report also offers detailed
   Nu Skin Enterprises Stock Gives Every Indication Of Being Fairly Valued  2021/06/05 12:00:11 GuruFocus
Related Stocks: NUS ,
   Nu Skin Enterprises Consensus Indicates Potential 8.5% Upside  2021/06/04 12:24:24 DirectorsTalk
Nu Skin Enterprises found using ticker (NUS) have now 6 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 80 and 60 calculating the average target price we see 66. With the stocks previous close at 60.82 this now indicates there is a potential upside of 8.5%. The 50 day MA is 56.88 while the 200 day moving average is 54.42. The market cap for the company is $3,022m. Find out more information at: /> [stock_market_widget type="chart" symbol="NUS" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Nu Skin Enterprises develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products.
   Nu Skin Named the World's #1 Brand for Beauty Device Systems for Four Consecutive Years  2021/03/23 16:28:00 PR Newswire
PROVO, Utah, March 23, 2021 /PRNewswire/ -- Nu Skin, a global leader in innovative beauty and wellness products powered by its dynamic business opportunity platform, has been ranked the world's number one brand for beauty device systems for four consecutive years by Euromonitor…
   Anti-aging Drugs Market 2021-2027 | Industry Analysis By Key Manufacturers Galderma, Sanofi, L'OREAL, Pfizer, DermaFix, Merz Pharma, Nu Skin, BIOTIME, INC., Elysium Health Inc., La Roche- Posay  2021/03/02 14:06:47 OpenPR
Anti-aging Drugs Market research report delivers a comprehensive study on production capacity, consumption, import and export for all major regions across the world. Report provides is a professional inclusive study on the current state for the market. Analysis and discussion
   Nu Skin Enterprises (NYSE:NUS) Posts Earnings Results, Beats Expectations By $0.21 EPS  2021/02/11 19:27:44 Transcript Daily
Nu Skin Enterprises (NYSE:NUS) announced its earnings results on Thursday. The company reported $1.40 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.19 by $0.21, MarketWatch Earnings reports. Nu Skin Enterprises had a net margin of 6.54% and a return on equity of 19.18%. NYSE NUS traded down $9.22 on Thursday, reaching […]
   Nu Skin’s 4Q Profit Jumps 94%  2021/02/11 09:48:19 Smarter Analyst
Beauty and wellness solutions provider Nu Skin’s fourth-quarter diluted earnings per share (EPS) surged 94% to $1.40 year-on-year, beating the Street consensus of … The post Nu Skin’s 4Q Profit Jumps 94% appeared first on Smarter Analyst .
   Earnings Scheduled For February 11, 2021  2021/02/11 08:51:42 Benzinga
Companies Reporting Before The Bell • Bluerock Residential Growth REIT, Inc. Class A Common Stock (AMEX: BRG ) is expected to report quarterly loss at $0.55 per share on revenue of $54.86 million. • AllianceBernstein Holding (NYSE: AB ) is expected to report quarterly earnings at $0.81 per share on revenue of $805.56 million. • Applied Genetic (NASDAQ: AGTC ) is likely to report earnings for its second quarter. • Alnylam Pharmaceuticals (NASDAQ: ALNY ) is projected to report quarterly loss at $1.76 per share on revenue of $146.07 million. • Alithya Group (NASDAQ: ALYA ) is expected to report earnings for its third quarter. • AstraZeneca (NASDAQ: AZN ) is likely to report quarterly earnings at $0.68 per share on revenue of $6.97 billion. • Coca-Cola European (NYSE: CCEP ) is expected to report earnings for its fourth quarter. • Cohu (NASDAQ: COHU ) is expected to report quarterly earnings at $0.61 per share on revenue of $197.76 million. • CSP (NASDAQ: CSPI ) is estimated to report earnings for its first quarter.

 関連キーワード  (トイレタリ―用品 米国株 NUS ニュ― スキン エンタ―プライズ NUS )

 twitter  (公式ツイッターやCEOツイッターなど)